Identification and validation of a DNA methylation-block prognostic model in non-small cell lung cancer patients
Abstract Background During perioperative care for non-small cell lung cancer (NSCLC) patients, clinical outcomes vary significantly. There is a critical need for more dependable biomarkers to identify high-risk individuals in the perioperative phase. This is essential for enhancing postoperative int...
Saved in:
| Main Authors: | Hang Li, Yi Lu, Haiqing Chen, Tong Li, Fangqiu Fu, Jing Wang, Bing Li, Hong Hu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-06-01
|
| Series: | BMC Cancer |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12885-025-14382-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of DNA methylation on the recurrence risk of stage I non-small cell lung cancer with EGFR mutations
by: Yunyi Li, et al.
Published: (2025-06-01) -
Multiplexed Methylated DNA Immunoprecipitation Sequencing (Mx-MeDIP-Seq) to Study DNA Methylation Using Low Amounts of DNA
by: Inam Ridha, et al.
Published: (2024-10-01) -
Advancements in DNA methylation technologies and their application in cancer diagnosis
by: Yang Yang, et al.
Published: (2025-12-01) -
Recent advances in biosensors for analysis of DNA/RNA methylation
by: Zhensheng Ma, et al.
Published: (2024-12-01) -
A review of the use of tumour DNA methylation for breast cancer subtyping and prediction of outcomes
by: Elaheh Zarean, et al.
Published: (2025-07-01)